1. Home
  2. DLPN vs SCNX Comparison

DLPN vs SCNX Comparison

Compare DLPN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.09

Market Cap

14.6M

ML Signal

HOLD

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.30

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
SCNX
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Other Pharmaceuticals
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
16.2M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
DLPN
SCNX
Price
$1.09
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
6.3K
299.3K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
N/A
EPS
N/A
N/A
Revenue
$56,699,389.00
$3,831,778.00
Revenue This Year
$14.73
$1,097.38
Revenue Next Year
$7.41
$239.80
P/E Ratio
N/A
N/A
Revenue Growth
9.70
30.72
52 Week Low
$1.02
$0.24
52 Week High
$1.88
$2.60

Technical Indicators

Market Signals
Indicator
DLPN
SCNX
Relative Strength Index (RSI) 44.92 27.72
Support Level $1.06 $0.30
Resistance Level $1.20 $0.43
Average True Range (ATR) 0.05 0.02
MACD -0.01 -0.01
Stochastic Oscillator 29.37 1.65

Price Performance

Historical Comparison
DLPN
SCNX

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Share on Social Networks: